Pharmaceutical promotions and trustworthiness on new drug prescribing among physicians in public general hospitals

Deldar Morad Abdulah, K. Perot
{"title":"Pharmaceutical promotions and trustworthiness on new drug prescribing among physicians in public general hospitals","authors":"Deldar Morad Abdulah, K. Perot","doi":"10.5430/jha.v8n6p17","DOIUrl":null,"url":null,"abstract":"Objective: The interaction between physicians and the pharmaceutical industry influences physicians’ attitudes and prescribing behaviors. In this regard, physicians’ attitudes towards pharmaceutical promotions and their trustworthiness towards pharmaceutical representatives’ information on new drugs were explored in this study.Methods: The present study was an analysis of a cross-sectional survey of 183 physicians with different job and education hierarchies and from various clinical settings in Erbil-Iraqi Kurdistan in July 2018. The physicians were invited from the public sector, comprising a general, emergency, and pediatric hospital. The information was collected through an anonymous, self-administered questionnaire. The questionnaire included exposure to marketing activities, motivations to contact pharmaceutical representatives, attitudes towards promotional activities, and trustworthiness of the pharmaceutical representatives’ information on new drugs.Results: Majority of the physicians reported that the information provided by pharmaceutical representatives assisted them in staying up to date or learning about new products (76.5%), but 55.7% of them trusted their medical information. In addition, most of them reported that pharmaceutical representatives prioritized the promotion of their products over patients’ benefits (70.5%). They reported that receiving promotional material and participating in promotional activities have an effect on doctors’ behaviors to prescribe a new drug, including promotional materials (55.2%); medical samples (67.8%); funding of registration costs to conferences (60.1%); participation in industry-funded researches (69.9%); and continuing medical education (69.4%). Receiving promotional materials and participation in promotional activities were considered to be ethical.Conclusions: The present study showed that most of the physicians reported the role of promotional materials and activities on physicians’ behaviors to prescribe new drugs.","PeriodicalId":15872,"journal":{"name":"Journal of Hospital Administration","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hospital Administration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5430/jha.v8n6p17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Objective: The interaction between physicians and the pharmaceutical industry influences physicians’ attitudes and prescribing behaviors. In this regard, physicians’ attitudes towards pharmaceutical promotions and their trustworthiness towards pharmaceutical representatives’ information on new drugs were explored in this study.Methods: The present study was an analysis of a cross-sectional survey of 183 physicians with different job and education hierarchies and from various clinical settings in Erbil-Iraqi Kurdistan in July 2018. The physicians were invited from the public sector, comprising a general, emergency, and pediatric hospital. The information was collected through an anonymous, self-administered questionnaire. The questionnaire included exposure to marketing activities, motivations to contact pharmaceutical representatives, attitudes towards promotional activities, and trustworthiness of the pharmaceutical representatives’ information on new drugs.Results: Majority of the physicians reported that the information provided by pharmaceutical representatives assisted them in staying up to date or learning about new products (76.5%), but 55.7% of them trusted their medical information. In addition, most of them reported that pharmaceutical representatives prioritized the promotion of their products over patients’ benefits (70.5%). They reported that receiving promotional material and participating in promotional activities have an effect on doctors’ behaviors to prescribe a new drug, including promotional materials (55.2%); medical samples (67.8%); funding of registration costs to conferences (60.1%); participation in industry-funded researches (69.9%); and continuing medical education (69.4%). Receiving promotional materials and participation in promotional activities were considered to be ethical.Conclusions: The present study showed that most of the physicians reported the role of promotional materials and activities on physicians’ behaviors to prescribe new drugs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
公立综合医院医师新药处方的药学推广与诚信
目的:医生与制药行业的互动影响医生的态度和处方行为。为此,本研究探讨了医生对药品促销的态度以及对药品代表新药信息的信任程度。方法:本研究对2018年7月在埃尔比勒-伊拉克库尔德斯坦不同临床环境中183名不同工作和教育层次的医生进行横断面调查。这些医生是从包括普通医院、急诊医院和儿科医院在内的公共部门邀请来的。这些信息是通过一份匿名的、自我管理的问卷收集的。问卷内容包括市场营销活动、联系医药代表的动机、对促销活动的态度以及医药代表对新药信息的可信度。结果:绝大多数医师认为医药代表提供的信息有助于他们及时了解或了解新产品(76.5%),但55.7%的医师相信医药代表提供的信息。此外,他们中的大多数人报告说,制药代表优先推广他们的产品,而不是患者的利益(70.5%)。受访医生表示,收到促销材料和参与促销活动对医生开新药的行为有影响,包括促销材料(55.2%);医学样本(67.8%);会议注册费用的资助(60.1%);参与业界资助的研究(69.9%);继续医学教育(69.4%)。接受宣传材料和参与宣传活动被认为是合乎道德的。结论:本研究显示,大多数医生报告了宣传材料和活动对医生开新药行为的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The reality of patient bodily waste management: Nurse perceptions of current practice & staff safety Facilitators and barriers for high-reliability training in medical centers Quality of care and emergency department throughput during the COVID-19 pandemic in a community health system Pandemic in a Community Health System Comparison of nursing staffing ratio in selected safety net and non-safety net hospitals in the United States Challenges and opportunities in achieving secure hospital clinical mobility management: An illustrative use case
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1